Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 5,415 $ 46
Accounts receivable, net (including related party receivable of $28,973 and $21,852 at December 31, 2022 and December 31, 2021, respectively) 36,226 32,800
Total current assets 41,641 32,846
Property and equipment, net
Total assets 41,641 32,846
Current liabilities:    
Accounts payable 1,239,945 937,698
Accrued expenses 1,638,071 1,446,722
Due to Former Parent 374,473
Current portion of notes payable (including related party debt of $1,438,269 at December 31, 2022) 1,572,422 134,153
Total current liabilities 4,450,438 2,893,046
Notes payable – Long term 60,401 60,401
Total liabilities 13,734,485 12,161,843
Commitments and contingencies
Stockholders’ Deficit    
Preferred Series A-1 Stock, Par Value $0.0001, 1,000 shares authorized, 1,000 shares issued and outstanding at December 31, 2022 and December 31, 2021
Common Stock, Par Value $0.0001, 325,000,000 shares authorized, 244,953,286 and 234,953,286 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively 24,495 23,495
Additional Paid-In Capital 5,906,742 5,857,658
Accumulated Deficit (19,624,081) (18,010,150)
Total Stockholders’ Deficit (13,692,844) (12,128,997)
Total Liabilities and Stockholders’ Deficit 41,641 32,846
Series B-1 Preferred Stock [Member]    
Current liabilities:    
Total temporary equity 9,086,396 9,086,396
Series C-1 Preferred Stock [Member]    
Current liabilities:    
Total temporary equity $ 137,250 $ 122,000